• SAR131675: Applied VEGFR-3 Inhibitor Workflows and Troublesh

  2026-04-23

  SAR131675 stands apart as a precision tool for dissecting lymphangiogenesis and angiogenesis in cancer and fibrosis models, thanks to its nanomolar potency and unparalleled selectivity. This article delivers actionable workflows, protocol refinements, and expert troubleshooting, empowering researchers to achieve robust, reproducible results in VEGFR-3–driven pathway studies.

• Magnetic Bispecific Nano-antibodies Enable In Vivo CAR-T Mim

  2026-04-22

  This study introduces a magnetic bispecific nano-antibody (M-BiNanoAb) platform for in vivo generation and magnetic guidance of CAR-T-mimicking cells, overcoming key barriers to solid tumor immunotherapy. The approach reprograms endogenous T cells with dual specificity, enabling precise tumor infiltration and demonstrating robust antitumor efficacy in preclinical models.

• Machine Learning for Mechanism of Action Prediction Across C

  2026-04-22

  This study systematically compares ensemble-based tree classifiers and deep convolutional neural networks (CNNs) for predicting compound mechanisms of action (MoA) based on high-content imaging data. It reveals that while both approaches perform comparably within individual cell lines, ensemble tree models exhibit superior transferability across morphologically distinct cell lines, highlighting challenges in generalizing deep learning models in phenotypic drug discovery.

• Redefining High-Resolution Protein Purification with HyperTr

  2026-04-21

  Explore how the HyperTrap Heparin HP Column leverages advanced HyperChrom Heparin HP Agarose for precise purification of critical biomolecules. This article uniquely analyzes assay optimization and stemness pathway research supported by recent molecular oncology findings.

• DEAF1 Drives Adriamycin Resistance in Multiple Myeloma via D

  2026-04-21

  This study identifies DEAF1 as a transcription factor that confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma. By dissecting its molecular interactions and downstream effects, the research highlights new therapeutic targets for overcoming chemoresistance in MM.

• Metoprolol in Translational Cardiovascular & Tumor Biology R

  2026-04-20

  Explore how Metoprolol, a selective beta1-adrenoceptor antagonist, uniquely empowers translational research across cardiovascular and tumor biology. This article offers advanced protocol insights and connects recent pharmacokinetic breakthroughs to practical assay design.

• Primidone and Aromatase: Dissecting Selectivity Among AEDs

  2026-04-20

  This study systematically evaluated the inhibitory effects of twelve antiepileptic drugs on human aromatase (CYP19) activity in vitro. Notably, Primidone (Mysoline) showed no detectable inhibition, distinguishing it mechanistically from several AEDs linked to endocrine disruption. The findings help clarify the safety profile of Primidone in research and clinical contexts where hormonal balance is critical.

• Probenecid (4-(dipropylsulfamoyl)benzoic acid): MRP Inhibiti

  2026-04-19

  Probenecid is a potent inhibitor of organic anion transporters and multidrug resistance-associated proteins, with additional neuroprotective effects in cerebral ischemia models. Its multifaceted action enables reversal of multidrug resistance in tumor cells and suppression of neuroinflammatory pathways. APExBIO supplies Probenecid for research use, supporting advanced oncology and neuroscience workflows.

• Optimizing Apoptosis and Viability Assays with DAPI Solution

  2026-04-18

  This article presents a scenario-driven, evidence-based guide for biomedical researchers and laboratory professionals seeking robust nuclear staining and viability assessment in cell-based assays. Through real-world laboratory challenges, we demonstrate how 'DAPI Solution (1 mg/mL)' (SKU K2401) from APExBIO delivers reproducible results, workflow reliability, and practical protocol flexibility for applications from apoptosis detection to flow cytometry.

• Practical Guide: Live-Dead Cell Staining Kit (SKU K2081) Use

  2026-04-17

  The Live-Dead Cell Staining Kit (SKU K2081) addresses the need for reliable and simultaneous discrimination of viable and non-viable cells in cultured populations, particularly for fluorescence-based assays. It is suitable for cell viability and cytotoxicity workflows in research but is not intended for diagnostic or clinical applications.

• Fingolimod (FTY720): Precision Immunomodulation for In Vivo

  2026-04-16

  Explore how Fingolimod (FTY720) extends beyond multiple sclerosis therapy as a platform for in vivo immunomodulation and T cell engineering, with new insights from CAR-T-mimicking cell generation studies. This article offers an in-depth, evidence-based analysis for advanced immunotherapy research.

• Live-Dead Cell Staining Kit: Practical Guide for Cell Viabil

  2026-04-15

  The Live-Dead Cell Staining Kit (SKU: K2081) enables researchers to distinguish live from dead cells in culture using a dual-dye system. It is best suited for fluorescence-based cell viability assays, including flow cytometry and microscopy, but is not intended for diagnostic or clinical use. Researchers should use this kit for high-contrast viability assessment, but not for applications requiring metabolic or functional readouts beyond membrane integrity.

• EAGLE-2/3 Trials: Gepotidacin vs. Nitrofurantoin in UTI Mana

  2026-04-14

  The EAGLE-2 and EAGLE-3 phase 3 trials investigated the efficacy and safety of oral gepotidacin, a first-in-class triazaacenaphthylene antibiotic, compared with standard nitrofurantoin for uncomplicated urinary tract infections (UTIs) in females. Gepotidacin demonstrated non-inferiority and, in one trial, superiority to nitrofurantoin, with a favorable safety profile and potential utility against resistant uropathogens.

• Merimepodib (VX-497): Advanced Protocols for Antiviral Resea

  2026-04-13

  Merimepodib (VX-497) sets a new benchmark as a noncompetitive, orally bioavailable IMPDH inhibitor, enabling robust experiments in cancer, immunology, and antiviral research. This guide translates cutting-edge findings into detailed workflows, troubleshooting, and optimization strategies to maximize success with APExBIO's Merimepodib.

• Chlorambucil in Precision Oncology: Mechanistic Insights and

  2026-04-13

  Explore the multifaceted role of Chlorambucil as a nitrogen mustard alkylating agent in cancer research, focusing on its DNA replication inhibition and advanced in vitro assay evaluation. This article delivers a unique, practical analysis grounded in recent scientific innovation.

16543 records 1/1103 page Next 12345 下5页 Last page